These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1802290)

  • 21. Measles seroepidemiology among adolescents and young adults: response to revaccination.
    Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
    East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Questioning the level of efficacy of the measles vaccine in use in Zimbabwe.
    Marufu T; Siziya S; Manyame B; Xaba E; Silape-Marufu Z; Zimbizi P; Ruwodo C; Mason E; Matchaba-Hove RB; Mudyarabikwa O
    Cent Afr J Med; 1995 Aug; 41(8):241-5. PubMed ID: 7585910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Measles epidemiology and the status of specific immunity in Novgorod Province during a mass immunization].
    Golubeva LI; Brantseva IV
    Tr Inst Im Pastera; 1985; 62():68-72. PubMed ID: 2954277
    [No Abstract]   [Full Text] [Related]  

  • 24. [The state of measles immunity and the success quota of measles vaccination in Basle nursery and elementary school pupils].
    Just M; Baechlin A; Berger R; Bürgin-Wolff A
    Schweiz Med Wochenschr; 1980 Apr; 110(14):528-30. PubMed ID: 7375902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survey of immunity to measles in schoolchildren in Cork.
    Foley-Nolan C; Conlon C; Keane E; O'Sullivan M; Ryan F
    Commun Dis Rep CDR Rev; 1996 Nov; 6(12):R172-5. PubMed ID: 8972981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immuno-epidemiologic considerations on the prevention of measles in Mexico].
    Díaz-Ortega JL; Valdespino-Gómez JL; Zárate-Aquino ML; Camacho-Amor ML; González-Velázquez MS; Chávez-San Juan R
    Bol Med Hosp Infant Mex; 1990 Jul; 47(7):474-81. PubMed ID: 2206412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of immunity to measles between floating and local population].
    Sun LY; Bai TJ; Rong JR
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1053-4. PubMed ID: 19173898
    [No Abstract]   [Full Text] [Related]  

  • 28. [The measles epidemiologic process in the context of active immunization].
    Buzdugan I; Romaniuc A; Dumitrache D; Oană C; Brebenel G; Nicola P; Damian M; Bogus L; Blaga G
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(1):61-6. PubMed ID: 4070878
    [No Abstract]   [Full Text] [Related]  

  • 29. Viral hepatitis in Bucharest.
    Paquet C; Babes VT; Drucker J; Sénémaud B; Dobrescu A
    Bull World Health Organ; 1993; 71(6):781-6. PubMed ID: 8313496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The epidemiological efficacy of mass vaccination against measles among the troops].
    Sibilev VI; Shevtsova VA; Tiasto EA
    Voen Med Zh; 1994 Feb; (2):50-1, 80. PubMed ID: 8165796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of urban measles mass campaigns for children aged 9-59 months in Mali.
    Kertesz DA; Touré K; Berthé A; Konaté Y; Bougoudogo F
    J Infect Dis; 2003 May; 187 Suppl 1():S69-73. PubMed ID: 12721894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The epidemiology of measles in England and Wales since the 1994 vaccination campaign.
    Gay N; Ramsay M; Cohen B; Hesketh L; Morgan-Capner P; Brown D; Miller E
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R17-21. PubMed ID: 9046124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a measles vaccine efficacy during a measles outbreak in Mbare, City of Harare Zimbabwe.
    Mahomva AI; Moyo IM; Mbengeranwa LO
    Cent Afr J Med; 1997 Sep; 43(9):254-6. PubMed ID: 9509644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Postvaccinal measles immunity characteristics of Leningrad children].
    Smorodinova IP; Zubov AK; Sobolevskaia AA; Kaplan AS; Smordintsev AA
    Tr Inst Im Pastera; 1979; 53():66-70. PubMed ID: 162464
    [No Abstract]   [Full Text] [Related]  

  • 35. Measles antibody response in vaccinated children.
    Evliyaoğlu N; Altintaş D; Kiliç NB; Alhan SE; Onenli N; Güneşer S; Bahçebaşi T
    Turk J Pediatr; 1996; 38(3):315-21. PubMed ID: 8827900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiological study of measles in Ghazvin, Islamic Republic of Iran, April 1997-April 2003.
    Asefzadeh M; Peyrovian B
    East Mediterr Health J; 2006; 12(1-2):14-22. PubMed ID: 17037218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran.
    Pourabbas B; Ziyaeyan M; Alborzi A; Mardaneh J
    Int J Infect Dis; 2008 Jan; 12(1):43-6. PubMed ID: 17950020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA; Barakat SS; Abd El Fattah MM; Said ZN; El Metwally HA
    East Mediterr Health J; 2009; 15(1):85-93. PubMed ID: 19469430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Misplaced loss of confidence in measles vaccination: an investigation in a primary school.
    Hicks NR
    J R Coll Gen Pract; 1989 Apr; 39(321):151-2. PubMed ID: 2559990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmission of measles among a highly vaccinated school population--Anchorage, Alaska, 1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jan; 47(51-52):1109-11. PubMed ID: 9921727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.